These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22495425)

  • 1. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.
    Himes SK; Goodwin RS; Rock CM; Jones HE; Johnson RE; Wilkins DG; Huestis MA
    Ther Drug Monit; 2012 Jun; 34(3):337-44. PubMed ID: 22495425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Clin Chem; 2011 Mar; 57(3):449-58. PubMed ID: 21245372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence Syndrome.
    Metzger IF; Thomas AE; Evrard CA; Jones DR; Masters AR; Haas DM; Haneline LS; Quinney SK
    Am J Perinatol; 2021 Jul; 38(9):968-975. PubMed ID: 32052397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
    Jansson LM; Dipietro JA; Elko A; Velez M
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.
    Jones HE; Jansson LM; O'Grady KE; Kaltenbach K
    Neurotoxicol Teratol; 2013; 39():110-5. PubMed ID: 24099621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
    Bivin B; Waring A; Alves P
    J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
    Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
    Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone and perinatal outcomes: a prospective cohort study.
    Cleary BJ; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
    Addiction; 2012 Aug; 107(8):1482-92. PubMed ID: 22340442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.